Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

200 Years of Lithium and 100 Years of Organolithium Chemistry.

ABSTRACT: The element lithium has been discovered 200 years ago. Due to its unique properties it has emerged to play a vital role in industry, esp. for energy storage, and lithium-based products and processes support sustainable technological developments. In addition to the many uses of lithium in its inorganic forms, lithium has a rich organometallic chemistry. The development of organometallic chemistry has been hindered by synthetic problems from the start. When Wilhelm Schlenk developed the basic principles to handle and synthesize air- and moisture-sensitive compounds, the road was open to further developments. After more information was available about the stability and solubility of such compounds, they started to play an essential role in other fields of chemistry as alkyl or aryl transfer reagents.

SUBMITTER: Wietelmann U

PROVIDER: S-EPMC5838519 | biostudies-other | 2018 Mar

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Publications

200 Years of Lithium and 100 Years of Organolithium Chemistry.

Wietelmann Ulrich U Klett Jan J

Zeitschrift fur anorganische und allgemeine Chemie 20180117 4

The element lithium has been discovered 200 years ago. Due to its unique properties it has emerged to play a vital role in industry, esp. for energy storage, and lithium-based products and processes support sustainable technological developments. In addition to the many uses of lithium in its inorganic forms, lithium has a rich organometallic chemistry. The development of organometallic chemistry has been hindered by synthetic problems from the start. When <i>Wilhelm Schlenk</i> developed the ba ...[more]

PMID: 29540939

Similar Datasets

Assessing changes in groundwater chemistry in landscapes with more than 100 years of oil and gas development.

Project description:With recent improvements in high-volume hydraulic fracturing (HVHF, known to the public as fracking), vast new reservoirs of natural gas and oil are now being tapped. As HVHF has expanded into the populous northeastern USA, some residents have become concerned about impacts on water quality. Scientists have addressed this concern by investigating individual case studies or by statistically assessing the rate of problems. In general, however, lack of access to new or historical water quality data hinders the latter assessments. We introduce a new statistical approach to assess water quality datasets - especially sets that differ in data volume and variance - and apply the technique to one region of intense shale gas development in northeastern Pennsylvania (PA) and one with fewer shale gas wells in northwestern PA. The new analysis for the intensely developed region corroborates an earlier analysis based on a different statistical test: in that area, changes in groundwater chemistry show no degradation despite that area's dense development of shale gas. In contrast, in the region with fewer shale gas wells, we observe slight but statistically significant increases in concentrations in some solutes in groundwaters. One potential explanation for the slight changes in groundwater chemistry in that area (northwestern PA) is that it is the regional focus of the earliest commercial development of conventional oil and gas (O&G) in the USA. Alternate explanations include the use of brines from conventional O&G wells as well as other salt mixtures on roads in that area for dust abatement or de-icing, respectively.

| S-EPMC6384141 | biostudies-literature

100 Years of Suramin.

Project description:Suramin is 100 years old and is still being used to treat the first stage of acute human sleeping sickness, caused by Trypanosoma bruceirhodesiense Suramin is a multifunctional molecule with a wide array of potential applications, from parasitic and viral diseases to cancer, snakebite, and autism. Suramin is also an enigmatic molecule: What are its targets? How does it get into cells in the first place? Here, we provide an overview of the many different candidate targets of suramin and discuss its modes of action and routes of cellular uptake. We reason that, once the polypharmacology of suramin is understood at the molecular level, new, more specific, and less toxic molecules can be identified for the numerous potential applications of suramin.

| S-EPMC7038244 | biostudies-literature

Happy Birthday, Bronchiectasis: 200 Years of Targeting Mucus.

Project description: Not available

| S-EPMC7068825 | biostudies-literature

200 years of taxonomic confusion: Sporendonema and allies.

Project description:The genus Sporendonema (Gymnoascaceae, Onygenales) was introduced in 1827 with the type species S. casei for a red mould on cheese. Cheese is a consistent niche for this species. Sphaerosporium equinum is another species classified in Gymnoascaceae and has also been reported from cheese. Recently, other habitats have been reported for both Sporendonema casei and Sphaerosporium equinum. The present study aimed to investigate the taxonomy of Sporendonema and Sphaerosporium, as well as a close neighbour, Arachniotus. Two strains of Hormiscium aurantiacum, another related cheese-associated species were also included in the analyses. Strains were evaluated in terms of macro- and micromorphology, physiology including salt tolerance, growth rate at different temperatures, casein degradation, cellulase activity, lipolytic activity, and multi-locus phylogeny with sequences of the nuclear ribosomal internal transcribed spacer region, the D1-D2 region of the large subunit and partial β-tubulin locus sequences. The results showed that the analysed species were congeneric, and the generic names Arachniotus and Sphaerosporium should be reduced to the synonymy of Sporendonema. Therefore, four new combinations as well as one lectotype and one epitype were designated in Sporendonema. Two strains attributed to Sphaerosporium equinum from substrates other than cheese were found to be phylogenetically and morphologically deviant and were introduced as a new species named Sporendonema isthmoides.

| S-EPMC10940481 | biostudies-literature

Flexible and stable high-energy lithium-sulfur full batteries with only 100% oversized lithium.

Project description:Lightweight and flexible energy storage devices are urgently needed to persistently power wearable devices, and lithium-sulfur batteries are promising technologies due to their low mass densities and high theoretical capacities. Here we report a flexible and high-energy lithium-sulfur full battery device with only 100% oversized lithium, enabled by rationally designed copper-coated and nickel-coated carbon fabrics as excellent hosts for lithium and sulfur, respectively. These metallic carbon fabrics endow mechanical flexibility, reduce local current density of the electrodes, and, more importantly, significantly stabilize the electrode materials to reach remarkable Coulombic efficiency of >99.89% for a lithium anode and >99.82% for a sulfur cathode over 400 half-cell charge-discharge cycles. Consequently, the assembled lithium-sulfur full battery provides high areal capacity (3?mA?h cm-2), high cell energy density (288?W?h?kg-1 and 360?W?h?L-1), excellent cycling stability (260 cycles), and remarkable bending stability at a small radius of curvature (<1?mm).

| S-EPMC6203774 | biostudies-literature

Advances in Parkinson's Disease: 200 Years Later.

Project description:When James Parkinson described the classical symptoms of the disease he could hardly foresee the evolution of our understanding over the next two hundred years. Nowadays, Parkinson's disease is considered a complex multifactorial disease in which genetic factors, either causative or susceptibility variants, unknown environmental cues, and the potential interaction of both could ultimately trigger the pathology. Noteworthy advances have been made in different fields from the clinical phenotype to the decoding of some potential neuropathological features, among which are the fields of genetics, drug discovery or biomaterials for drug delivery, which, though recent in origin, have evolved swiftly to become the basis of research into the disease today. In this review, we highlight some of the key advances in the field over the past two centuries and discuss the current challenges focusing on exciting new research developments likely to come in the next few years. Also, the importance of pre-motor symptoms and early diagnosis in the search for more effective therapeutic options is discussed.

| S-EPMC6306622 | biostudies-other

The lithium effect in ketenyl anion chemistry.

Project description:Ketenyl lithium compounds of type [RC(Li)CO] (with R = Ph2P(E), E = O, S, Se) were found to exhibit lower thermal stabilities than their potassium analogues due to the stronger coordination of the oxygen of the ketene moiety to the harder metal cation, resulting in a more pronounced ynolate character. Using additional ligands allows manipulation of the O-Li interaction, thereby influencing the stability and reactivity of the ketenyl anions.

| S-EPMC11322804 | biostudies-literature

Natural history collections recapitulate 200 years of faunal change.

Project description:Changing species assemblages represent major challenges to ecosystems around the world. Retracing these changes is limited by our knowledge of past biodiversity. Natural history collections represent archives of biodiversity and are therefore an unparalleled source to study biodiversity changes. In the present study, we tested the value of natural history collections for reconstructing changes in the abundance and presence of species over time. In total, we scrutinized 17 080 quality-checked records for 242 epibenthic invertebrate species from the North and Baltic Seas collected throughout the last 200 years. Our approaches identified eight previously reported species introductions, 10 range expansions, six of which are new to science, as well as the long-term decline of 51 marine invertebrate species. The cross-validation of our results with published accounts of endangered species and neozoa of the area confirmed the results for two of the approaches for 49 to 55% of the identified species, and contradicted our results for 9 to 10%. The results based on relative record trends were less validated. We conclude that, with the proper approaches, natural history collections are an unmatched resource for recovering early species introductions and declines.

| S-EPMC8059531 | biostudies-literature

Comparison of 100 U With 200 U of Intradetrusor OnabotulinumToxinA for Nonneurogenic Urgency Incontinence.

Project description:ObjectivesThe objective of this study was to compare efficacy and adverse events between 100 U and 200 U of onabotulinumtoxinA for 6 months in women with nonneurogenic urgency incontinence.MethodsThis is a secondary analysis of 2 multicenter randomized controlled trials assessing efficacy of onabotulinumtoxinA in women with nonneurogenic urgency incontinence; one compared 100 U to anticholinergics and the other 200 U to sacral neuromodulation. Of 307 women who received onabotulinumtoxinA injections, 118 received 100 U, and 189 received 200 U. The primary outcome was mean adjusted change in daily urgency incontinence episodes from baseline over 6 months, measured on monthly bladder diaries. Secondary outcomes included perceived improvement, quality of life, and adverse events. The primary outcome was assessed via a multivariate linear mixed model.ResultsWomen receiving 200 U had a lower mean reduction in urgency incontinence episodes by 6 months compared with 100 U (-3.65 vs -4.28 episodes per day; mean difference, 0.63 episodes per day [95% confidence interval (CI), 0.05-1.20]). Women receiving 200 U had lower perceptions of improvement (adjusted odds ratio, 0.32 [95% CI, 0.14-0.75]) and smaller improvement in severity score (adjusted mean difference, 12.0 [95% CI, 5.63-18.37]). Upon subanalysis of only women who were treated with prior anticholinergic medications, these differences between onabotulinumtoxinA doses were no longer statistically significant. There was no statistically significant difference in adverse events in women receiving 200 U (catheterization, 32% vs 23%; adjusted odds ratio, 1.4 [95% CI, 0.8-2.4]; urinary tract infection, 37% vs 27%; adjusted odds ratio, 1.5 [95% CI, 0.9-2.6]).ConclusionsA higher dose of onabotulinumtoxinA may not directly result in improved outcomes, but rather baseline disease severity may be a more important prediction of outcomes.

| S-EPMC8117667 | biostudies-literature

Celebrating 100 years of Drosophila research.

Project description:The seventeenth EMBO Conference on the Molecular and Developmental Biology of Drosophila took place in Kolymbari, Crete, between 20 and 26 June 2010. The conference covered a broad range of topics and much progress was made by combining two or more fields of study. Such combinations included quantitative approaches to cell and developmental biology, dissecting interrelations of physiology and development and integrated genomic analysis.

| S-EPMC2948200 | biostudies-other

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data